PharmaShots | Incisive News in 3 Shots

Subscribe Now

large

$MorphoSys Reports Submission of Tafasitamab's BLA to the US FDA to Treat Relapsed or Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL)$

MorphoSys Reports Submission of Tafasitamab's BLA to the US FDA to Treat Relapsed or Refractory Diffuse Large B Cell Lymphoma (r/r...

December 31, 2019

JHL Biotech Reports Randomization of Patients in P-III Study of JHL1101 for Diffuse Large B-Cell Lymphoma

JHL Biotech Reports Randomization of Patients in P-III Study of JHL1101 for Diffuse Large B-Cell Lymphoma

December 28, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us